強效抗癌劑1-Aroylindole及1-Aroylindoline類緣物之研究

Synthesis of 1-Aroylindoles and 1-Aroylindolines as Potent Anticancer Agents

吳姿誼(Zi-Yi Wu)

指導教授 ： 陳繼明

共同指導教授 ： 劉景平

臺北醫學大學/藥學院/藥學研究所/碩士(2007年)

摘要

基於生物等效性的概念，我們利用combretastatin A-4 (CA-4)為模版來合成兩類強效抗癌劑1-aroylindoles及1-aroylindolines，並且討論結構與活性的關係以及進行生物活性的評估。1-Aroylindoles是由不同取代的indoles與3,4,5-trimethoxybenzoic anhydride或 3,4,5-trimethoxybenzoyl chloride反應得到，而1-aroylindolines則是先將具有取代的indoles還原成indolines，再與3,4,5-trimethoxybenzoyl chloride或3,4,5-trimethoxy-2-nitrobenzoic acid反應得到。2-23的結構屬於1-aroylindoles，而25-30則屬於1-aroylindolines。
從抑制口腔上皮細胞癌KB細胞株生長的活性評估中得知，2、4、7、11、13、14、24及26的IC50濃度範圍在210-652 nM間，表現出中等抗癌活性，9、12及25的IC50分別為20 nM、8 nM以及87 nM，表現出強效抗癌活性，22的IC50為1.1 nM，比CA-4 (IC50為1.65 nM)的活性稍微增加，而最強效化合物23的IC50為0.16 nM，比CA-4強10倍。
結構與活性的關係資料顯示將C-5位置的methoxy以推電子基團如methyl (4)、5,6-methylenedioxy (7)、amino (11)或N,N-dimethylamino (12)來取代仍然保持強效抗癌活性。在1-aroylindole的C-2位置有methyl基團取代可增加活性。而在C-3位置有取代基則失去活性。藉由仿照AVE-8063及combretastatin A-4分別導入amino和hydroxyl官能基於1-aroylindole的C-4位置，架構出22和23，可得到最佳的抗癌活性。

關鍵字

抗癌劑 ； 吲哚吲哚啉

並列摘要

Two classes of 1-aroylindoles and 1-aroylindolines were synthesized as potent anticancer agents based on the bioisosterism concept utilizing combretastatin A-4 (CA-4) as a template. 1-Aroylindoles were prepared by reacting substituted indoles with 3,4,5-trimethoxybenzoic anhydride or 3,4,5-trimethoxybenzoyl chloride. 1-Aroylindolines were prepared by reducing substituted indoles to indolines and then reacting with 3,4,5-trimethoxybenzoyl chloride or 3,4,5-trimethoxy-2-nitrobenzoic acid. 2-23 belong to 1-aroylindoles and 25-30 belong to 1-aroylindolines. Structure-activity relationship study was also discussed.
2, 4, 7, 11, 13, 14, 24 and 26 showed moderate cytotoxicities with IC50 values of 210-652 nM in inhibiting oral epidermoid carcinoma KB cell growth in vitro. 9, 12 and 25 exhibited potent cytotoxicities with IC50 values of 20 nM, 8 nM, and 87 nM, respectively. 22 showed a slight increase in activity with IC50 values of 1.1 nM as compared to CA-4 (IC50 values of 1.65 nM). The most potent compound 23 showed strong antiproliferative activity against KB cell line with IC50 values of 0.16 nM, 10-fold more potent than CA-4.
The structure-activity relationship study of these compounds revealed that the methoxy group at the C-5 position could be replaced with an electron-donating group such as methyl (4), 5,6-methylenedioxy (7), amino (11) or N,N-dimethylamino (12) while retaining strong cytotoxicity. Addition of a methyl group at the C-2 position in 1-aroylindole increased the cytotoxic potency. Substitution at the C-3 position led to a substantial loss of potency. The introduction of 4-amino and 4-hydroxy substitution in the 1-aroylindole gave 22 and 23, which contribute to significant extent for maximal activity by mimicking AVE-8063 and combretastatin A-4 respectively.

並列關鍵字

anticancer agents ； indoles ； indolines

參考文獻

3.Katzung, B. G., Basic and Clinical Pharmacology. McGraw-Hill Press, 8 ed.; 2001; p 923-944.

4.Pettit, G. R.; Cragg, G. M.; Herald, D. L.; Schmidt, J. M.; Lohavanijaya, P., Isolation and structure of combretastatin. Can. J. Chem. 1982, 60, 1374-1376.

5.Pettit, G. R.; Singh, S. B., Isolation, structure, and synthesis of combretastatin A-2, A-3, and B-2. Can. J. Chem. 1987, 65, 2390-2396.

6.Pettit, G. R.; Singh, S. B.; Niven, M. L., Isolation and Structure of Combretastatin D-1: A Cell Growth Inhibitory Macrocyclic Lactone from Combretum caffrum. J. Am. Chem. Soc. 1988, 110, 8539-8540.

7.Singh, S. B.; Pettit, G. R., Antineoplastic Agents. 206. Structure of the Cytostatic Macrocyclic Lactone Combretastatin D-2. J. Org. Chem. 1990, 55, 2797-2800.